Down Regulation of High in Normal-1 (HIN-1) is a Frequent Event in Stage I Non-Small Cell Lung Cancer and Correlates with Poor Clinical Outcome

Clinical Cancer Research

Volumn 10, Issue 4, 2004, Pages 1338-1343

  Marchetti, Antonio ^a   Barassi, Fabio ^a   Martella, Carla ^a   Chella, Antonio ^b   Salvatore, Simona ^a   Castrataro, Antonio ^a   Mucilli, Felice ^a   Sacco, Rocco ^a   Buttitta, Fiamma ^a  

^a UNIVERSITY OF CHIETI   (Italy)

^b UNIVERSITY OF PISA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; DNA SYNTHESIS; DOWN REGULATION; FEMALE; FISHER EXACT TEST; GENE EXPRESSION; HIN 1 GENE; HUMAN; HUMAN TISSUE; KAPLAN MEIER METHOD; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NUCLEOTIDE SEQUENCE; OUTCOMES RESEARCH; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; REAL TIME POLYMERASE CHAIN REACTION; REFERENCE VALUE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK FACTOR; RNA EXTRACTION; STATISTICAL ANALYSIS; TUMOR SUPPRESSOR GENE; VALIDATION PROCESS;

ADULT; AGED; CARCINOMA, NON-SMALL-CELL LUNG; CYTOKINES; DISEASE-FREE SURVIVAL; DNA PRIMERS; DNA, COMPLEMENTARY; DOWN-REGULATION; FEMALE; HUMANS; LUNG; LUNG NEOPLASMS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; POLYMERASE CHAIN REACTION; PROGNOSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TIME FACTORS; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEINS;

EID: 1642333964     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-1174-03     Document Type: Article

References (21)

1. Greenlee, R. T., Hill-Harmorn, M. B., Murray, T., and Thun, M. Cancer Statistics 2001. CA Cancer J. Clin., 51: 15-36, 2001.
2. Jemal, A., Thomas, A., Murray, T., and Thun, M. J. Cancer Statistics 2002. CA - Cancer J. Clin., 52: 23-47, 2002.
3. Pisters, K. M. W. Adjuvant and neoadjuvant therapy for early stage non-small cell lung cancer. Semin. Oncol., 28 (Suppl. 14): 23-28, 2001.
4. Osada, H., and Takahashi, T. Genetic alterations of multiple tumor suppressors and oncogenes in the carcinogenesis and progression of lung cancer. Oncogene, 2: 7421-7434, 2002.
5. Krop, I. E., Sgroi, D., Porter, D. A., Lunetta, K. L., LeVangie R., Seth, P., Kaelin C. M., Rhei, E., Rosenberg, M., Schnitt, S., et al. HIN-1, a putative cytokine highly expressed in normal but not cancerous mammary epithelial cells. Proc. Natl. Acad. Sci. USA, 98: 9796-9801, 2001.
6. Porter, D., Lahti-Domenici, J., Torres-Arzayus, M., Chin, L., and Polyak, K. Expression of high in normal-1 (HIN-1) and uteroglobin related protein-1 (UGRP-1) in adult and developing tissues. Mech. Dev., 114: 201-204, 2002.
7. Fong, K. M., Zimmerman, P. V., and Smith, P. J. Lung pathology: the molecular genetics of non-small cell lung cancer. Pathology, 27: 295-301, 1995.
8. Saric, T., Brkanac, Z., Troyer, D. A., Padalecki, S. S., Sarosdy, M., Williams, K., Abadesco, L., Leach, L. J., and O'Connel, P. Genetic pattern of prostate cancer progression. Int. J. Cancer, 81: 219-224, 1999.
9. Yamano, M., Fujii, H., Takagaki, T., Kadowaki, N., Watanabe, H., and Shirai, T. Genetic progression and divergence in pancreatic carcinoma. Am. J. Pathol., 156: 2123-2133, 2000.
10. Fong, K. M., Zimmerman, P. V., and Smith, P. J. Tumor progression and loss of heterozygosity at 5q and 18q in non-small cell lung cancer. Cancer Res., 55: 220-223, 1995.
11. Mendes-da-Silva, P., Moreira, A., Duro-da-Costa, J., Matias, D., and Monteiro, C. Frequent loss of heterozygosity on chromosome 5 in non-small cell lung carcinoma. Mol. Pathol., 53: 184-187, 2000.
12. Fleming, I. D., Cooper, J. S., Henson, D. E., Hutter, R. V. P., Kennedy, B. J., Murphy, G. P., O'Sullivan, B., Sobin, L. H., and Yarbro, J. W. (eds.), American Joint Committee on Cancer: Cancer Staging Manual, Ed. 5. Philadelphia: Lippincott-Raven, 1997.
13. Travis, T. D., Colby, T. V., Corrin, B., Shimosato, Y., and Brambilla, E. Histological classification of lung and pleural tumors. In: W. D. Travis (ed.), WHO International Histological Classification of Tumors: Histological Typing of Lung and Pleural Tumors, Ed. 3, pp. 21-26. Berlin: Springer, 1999.
14. Heid, C. A., Stevens, J., Livak, K. J., and Williams, P. M. Real Time Quantitative PCR. Genome Res., 6: 986-994, 1994.
15. Macgregor, P. F., and Squire, J. A. Application of microarrays to the analysis of gene expression in cancer. Clin. Chem., 48: 1170-1177, 2002.
16. Liang, P. A decade of differential display. Biotechniques, 33: 338-344, 2002.
17. Polyak, K., Riggins, G. J. Gene discovery using the serial analysis of gene expression technique: implications for cancer research. J. Clin. Oncol., 19: 2948-2958, 2001.
18. Pohl, M., Stuart, R. O., Sakurai, H., and Nigam, S. K. Branching morphogenesis during kidney development. Annu. Rev. Physiol., 62: 595-620, 2000.
19. Warburton, D., Schwarz, M., Tefft, D., Flores-Delgado, G., Anderson, K. D., and Cardoso, W. V. The molecular basis of lung morphogenesis. Mech. Dev., 92: 55-81, 2000.
20. Krop, I., Maguire, P., Lahti-Domenici, J., Lodeiro, G., Richardson, A., Johannsdottir, H. K., Nevanlinna, H., Borg, A., Gelman, R., Barkardottir, R. B., et al. Lack of HIN-1 Methylation in BRCA1-linked and "BRCA1-like" Breast Tumors. Cancer Res., 63: 2024-2027, 2003.
21. Baylin, S. B., and Herman, J. G. DNA hypermethylation in tumorigenesis: epigenetics joins genetics. Trends Genet., 16: 168-174, 2000.